Literature DB >> 30597564

Health Care Evolves From Reactive to Proactive.

Scott A Waldman1, Andre Terzic2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30597564      PMCID: PMC6314203          DOI: 10.1002/cpt.1295

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  18 in total

1.  Affairs of the Heart: Innovation in Cardiovascular Research and Development.

Authors:  P Honig; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2017-08       Impact factor: 6.875

2.  Precision Medicine-Nobody Is Average.

Authors:  A A Vinks
Journal:  Clin Pharmacol Ther       Date:  2017-03       Impact factor: 6.875

3.  Designer Drugs 2.0.

Authors:  M A Huestis; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2017-02       Impact factor: 6.875

Review 4.  Enhancing value of clinical pharmacodynamics in oncology drug development: An alliance between quantitative pharmacology and translational science.

Authors:  K Venkatakrishnan; J A Ecsedy
Journal:  Clin Pharmacol Ther       Date:  2016-11-25       Impact factor: 6.875

5.  Prenatal Regeneration in Clinical Practice.

Authors:  Scott A Waldman
Journal:  Mayo Clin Proc       Date:  2018-05-23       Impact factor: 7.616

Review 6.  Engineered Heart Repair.

Authors:  B Fujita; W-H Zimmermann
Journal:  Clin Pharmacol Ther       Date:  2017-06-29       Impact factor: 6.875

7.  Regenerative Musculoskeletal Care: Ensuring Practice Implementation.

Authors:  Daniel B F Saris; Tommy S de Windt; Lucienne A Vonk; Aaron J Krych; Andre Terzic
Journal:  Clin Pharmacol Ther       Date:  2017-10-16       Impact factor: 6.875

8.  Pediatric Drug Development: Outlook for Science-Based Innovation.

Authors:  Dionna J Green; Issam Zineh; Gilbert J Burckart
Journal:  Clin Pharmacol Ther       Date:  2018-01-31       Impact factor: 6.875

9.  Process Improvement for Maximized Therapeutic Innovation Outcome.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Pharmacol Ther       Date:  2018-01       Impact factor: 6.875

Review 10.  Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease.

Authors:  Robert N Schuck; Janet Woodcock; Issam Zineh; Peter Stein; Jonathan Jarow; Robert Temple; Thomas Permutt; Lisa LaVange; Julia A Beaver; Rosane Charlab; Gideon M Blumenthal; Sarah E Dorff; Christopher Leptak; Steven Lemery; Hobart Rogers; Badrul Chowdhury; E David Litwack; Michael Pacanowski
Journal:  Clin Pharmacol Ther       Date:  2018-02-23       Impact factor: 6.875

View more
  4 in total

Review 1.  Regenerative medicine clinical readiness.

Authors:  Satsuki Yamada; Atta Behfar; Andre Terzic
Journal:  Regen Med       Date:  2021-02-24       Impact factor: 3.806

2.  The Regenerative Horizon: Opportunities for Nursing Research and Practice.

Authors:  Linda L Chlan; Cindy Tofthagen; Andre Terzic
Journal:  J Nurs Scholarsh       Date:  2019-09-30       Impact factor: 3.176

Review 3.  Mass Customized Outlook for Regenerative Heart Failure Care.

Authors:  Satsuki Yamada; Jozef Bartunek; Atta Behfar; Andre Terzic
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

4.  Promoting Whole Health in the Dental Setting: Steps Toward an Integrated Interprofessional Clinical Learning Environment Involving Pharmacy, Social Work, and Nursing.

Authors:  Kimberly A Sanders; Lisa de Saxe Zerden; Meg Zomorodi; Katharine Ciarrocca; Karen L Schmitz
Journal:  Int J Integr Care       Date:  2021-11-18       Impact factor: 5.120

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.